Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score

Clinical Research in Cardiology

Volumn 104, Issue 4, 2015, Pages 334-341

  Franke, Jennifer ^a   Lindmark, Andreas ^a   Hochadel, Matthias ^a   Zugck, Christian ^a   Koerner, Eva ^a   Keppler, Jeannette ^a   Ehlermann, Philipp ^a   Winkler, Ralph ^b   Zahn, Ralf ^b   Katus, Hugo A ^a   Senges, Jochen ^a   Frankenstein, Lutz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Heart Center Ludwigshafen   (Germany)

Author keywords

Chronic heart failure; Gender; Heart Failure Survival Score; NT proBNP; Risk score

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; GERMANY; HEART FAILURE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX RATIO; SURVIVAL RATE;

BIOMARKERS; FEMALE; GERMANY; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84939966383     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0786-z     Document Type: Article

References (52)

1. Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R (2010) Sex and gender differences in myocardial hypertrophy and heart failure. Circ J: Off J Jpn Circ Soc 74(7):1265–1273
2. Hussey LC, Hardin S (2003) Sex-related differences in heart failure. Heart Lung: J Crit Care 32(4):215–223 quiz 224–215
3. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. JAMA, J Am Med Assoc 275(20):1557–1562
4. Frankenstein L, Clark AL, Ribeiro JP (2012) Influence of sex on treatment and outcome in chronic heart failure. Cardiovasc Ther 30(3):182–192. doi:10.1111/j.1755-5922.2010.00253.x
5. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29(2):270–276. doi:10.1093/eurheartj/ehm342
6. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart A, Council on Clinical Cardiology HF, Transplantation C, Quality of C, Outcomes R, Functional G, Translational Biology Interdisciplinary Working G, Council on E, Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807–1816. doi:10.1161/CIRCULATIONAHA.106.174287
7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing G, American Society of Echocardiography’s G, Standards C, European Association of E (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr 18(12):1440–1463. doi:10.1016/j.echo.2005.10.005
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W, American Society of Echocardiography’s N, Standards C, Task Force on Chamber Q, American College of Cardiology Echocardiography C, American Heart A, European Association of Echocardiography ESoC (2006) Recommendations for chamber quantification. Eur J Echocardiogr: J Work Group Echocardiogr Eur Soc Cardiol 7(2):79–108. doi:10.1016/j.euje.2005.12.014
9. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845
10. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95(12):2660–2667
11. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant:Off Publ Int Soc Heart Transplant 25(9):1024–1042. doi:10.1016/j.healun.2006.06.008
12. Goda A, Williams P, Mancini D, Lund LH (2011) Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM). J Heart Lung Transplant:Off Publ Int Soc Heart Transplant 30(11):1236–1243. doi:10.1016/j.healun.2011.05.012
13. Goda A, Lund LH, Mancini DM (2010) Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation. Am J Cardiol 105(10):1439–1444. doi:10.1016/j.amjcard.2009.12.067
14. Green P, Lund LH, Mancini D (2007) Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. Am J Cardiol 99(3):399–403. doi:10.1016/j.amjcard.2006.08.046
15. Parikh MN, Lund LH, Goda A, Mancini D (2009) Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure. Am J Cardiol 103(7):998–1002. doi:10.1016/j.amjcard.2008.12.010
16. Goda A, Lund LH, Mancini D (2011) The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. J Heart Lung Transplant:Off Publ Int Soc Heart Transplant 30(3):315–325. doi:10.1016/j.healun.2010.09.007
17. Bobbio M, Dogliani S, Giacomarra G (2004) Superiority of the heart failure survival score to peak exercise oxygen consumption in the prediction of outcomes in an independent population referred for heart transplant evaluation. Ital Heart J: Off J Ital Fed Cardiol 5(12):899–905
18. Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH (2000) Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 321(7260):540–545
19. Koelling TM, Joseph S, Aaronson KD (2004) Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 23(12):1414–1422. doi:10.1016/j.healun.2003.10.002
20. Butler J, Khadim G, Paul KM, Davis SF, Kronenberg MW, Chomsky DB, Pierson RN 3rd, Wilson JR (2004) Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 43(5):787–793. doi:10.1016/j.jacc.2003.08.058
21. Lund LH, Aaronson KD, Mancini DM (2003) Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol 92(11):1350–1354
22. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R (2002) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105(20):2392–2397
23. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38(7):1934–1941
24. Loke ISI, Davies JE, Ng LL (2003) Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 5(5):599–606
25. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40(5):976–982
26. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS (2002) Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90(3):254–258
27. Kara K, Mahabadi AA, Geisel MH, Lehmann N, Kalsch H, Bauer M, Neumann T, Dragano N, Moebus S, Mohlenkamp S, Jockel KH, Erbel R (2014) B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events—the Heinz Nixdorf Recall Study. Clin Res Cardiol: Off J Ger Card Soc 103(2):125–132. doi:10.1007/s00392-013-0628-4
28. Maffei S, Del Ry S, Prontera C, Clerico A (2001) Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clin Sci 101(5):447–453
29. Clark BA, Elahi D, Epstein FH (1990) The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. J Clin Endocrinol Metab 70(2):349–352. doi:10.1210/jcem-70-2-349
30. Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H (1998) Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro) renin levels in humans. J Hypertens 16(6):853–862
31. Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JG, Katus HA, Zugck C (2009) The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95(10):825–829. doi:10.1136/hrt.2008.158626
32. Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22(4 Suppl A):6A–13A
33. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88(1):107–115
34. Gustafsson F, Torp-Pedersen C, Burchardt H, Buch P, Seibaek M, Kjoller E, Gustafsson I, Kober L, Group DS (2004) Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J 25(2):129–135
35. Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL (2008) Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 10(2):140–148. doi:10.1016/j.ejheart.2007.12.012
36. Tasevska-Dinevska G, Kennedy LM, Cline-Iwarson A, Cline C, Erhardt L, Willenheimer R (2008) Gender aspects on survival among patients admitted to hospital with suspected or diagnosed heart failure. Scand Cardiovasc J: SCJ 42(6):383–391. doi:10.1080/14017430802226457
37. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P (2001) Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 103(3):375–380
38. Chun KR, Schmidt B, Kuck KH, Andresen D, Willems S, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Seidl K, Junger C, Horack M, Brachmann J, Senges J (2013) Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry. Clin Res Cardiol: Off J Ger Card Soc 102(6):459–468. doi:10.1007/s00392-013-0553-6
39. Shah SM, Carey IM, DeWilde S, Richards N, Cook DG (2008) Trends and inequities in beta-blocker prescribing for heart failure. Br J Gen Pract: J R Coll Gen Pract 58(557):862–869. doi:10.3399/bjgp08X376195
40. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N (2009) Evaluation of the management of heart failure in primary care. Fam Pract 26(2):145–153. doi:10.1093/fampra/cmn105
41. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J, Committees IoHFP Investigators, Improvement programme in e management, Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of C (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360(9346):1631–1639
42. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of C (2003) The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442–463
43. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of C (2003) The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24(5):464–474
44. de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, Jondeau G, Leurs I, Thebaut JF, Komajda M (2007) Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 9(12):1205–1211. doi:10.1016/j.ejheart.2007.09.008
45. Tebbe U, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Strunz AM, Lins K, Bohm M (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol: Off J Ger Card Soc. doi:10.1007/s00392-014-0678-2
46. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol: Off J Ger Card Soc 101(1):1–10. doi:10.1007/s00392-011-0348-6
47. Opasich C, De Feo S, Ambrosio GA, Bellis P, Di Lenarda A, Di Tano G, Fico D, Gonzini L, Lavecchia R, Tomasi C, Maggioni AP, Investigators T (2004) The ‘real’ woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists. Eur J Heart Fail 6(6):769–779. doi:10.1016/j.ejheart.2003.11.021
48. Rathore SS, Foody JM, Wang Y, Herrin J, Masoudi FA, Havranek EP, Ordin DL, Krumholz HM (2005) Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 149(1):121–128. doi:10.1016/j.ahj.2004.06.008
49. Galvao M, Kalman J, DeMarco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM (2006) Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Cardiac Fail 12(2):100–107. doi:10.1016/j.cardfail.2005.09.005
50. Baumhakel M, Muller U, Bohm M (2009) Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 11(3):299–303. doi:10.1093/eurjhf/hfn041
51. Aronson D, Burger AJ (2000) Gender-related differences in modulation of heart rate in patients with congestive heart failure. J Cardiovasc Electrophysiol 11(10):1071–1077
52. Konhilas JP (2010) What we know and do not know about sex and cardiac disease. J Biomed Biotechnol 2010:562051. doi:10.1155/2010/562051